Literature DB >> 27377524

Outcomes of Patients with Pulmonary Atresia and Major Aortopulmonary Collaterals Without Intervention in Infancy.

Michael L O'Byrne1, Joshua P Kanter2, John T Berger2, Richard A Jonas3.   

Abstract

Treatment of pulmonary atresia with major aortopulmonary collaterals (PA MAPCAs) remains a challenge. Despite variations in surgical technique, contemporary strategies all include initial intervention in the first year of life. However, a subset of patients presents later in life, and contemporary outcomes of this group have not been reported previously. We performed a retrospective case series of consecutive cases of PA MAPCAs who were seen at our center between January 2001 and February 2016, who had not undergone surgery before the age of 1 year. We describe their presenting characteristics, operative and transcatheter interventions, and outcomes. A total of eight cases were identified from 76 children with PA MAPCAs treated over the study period. Median age at presentation was 5.9 years. Seventy-five percent had confluent pulmonary arteries with a median Nakata index of 113 mm(2)/m(2). Operative intervention was performed in 5/6 cases. Two are awaiting intervention. The combination of operative and transcatheter interventions allowed for ventricular septal defect closure in 60 % of cases, all of whom had subsystemic right ventricular pressures. Operative intervention is possible in some older cases with PA and MAPCAs. Though multiple operations and transcatheter therapies are necessary, some can achieve operative correction of serial circulation with tolerable physiology. Subjects with ventricular hypoplasia and those without confluent pulmonary arteries are more challenging.

Entities:  

Keywords:  Congenital heart surgery; Heart catheterization; Outcomes research; Pediatric cardiology

Mesh:

Year:  2016        PMID: 27377524      PMCID: PMC5189909          DOI: 10.1007/s00246-016-1445-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  40 in total

Review 1.  Efficacy of bosentan therapy for segmental pulmonary artery hypertension due to major aortopulmonary collateral arteries in children.

Authors:  Kenichiro Yamamura; Hazumu Nagata; Kazuyuki Ikeda; Kenji Ihara; Toshiro Hara
Journal:  Int J Cardiol       Date:  2012-03-28       Impact factor: 4.164

Review 2.  Tetralogy of Fallot with major aortopulmonary collaterals: early total repair.

Authors:  D B McElhinney; V M Reddy; F L Hanley
Journal:  Pediatr Cardiol       Date:  1998 Jul-Aug       Impact factor: 1.655

3.  Staged operation for pulmonary atresia and ventricular septal defect with major aortopulmonary collateral arteries. New technique for complete unifocalization.

Authors:  K Sawatari; Y Imai; H Kurosawa; Y Isomatsu; K Momma
Journal:  J Thorac Cardiovasc Surg       Date:  1989-11       Impact factor: 5.209

4.  Preoperative total pulmonary blood flow predicts right ventricular pressure in patients early after complete repair of tetralogy of Fallot and pulmonary atresia with major aortopulmonary collateral arteries.

Authors:  Lars Grosse-Wortmann; Shi-Joon Yoo; Glen van Arsdell; Devin Chetan; Cathy Macdonald; Lee Benson; Osami Honjo
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-12       Impact factor: 5.209

5.  Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients.

Authors:  V M Reddy; D B McElhinney; Z Amin; P Moore; A J Parry; D F Teitel; F L Hanley
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

6.  Pulmonary atresia with ventricular septal defect and multifocal pulmonary blood supply: does an intensive interventional approach improve the outcome?

Authors:  Christopher Learn; Alistair Phillips; Joanne Chisolm; Sharon Hill; John Cheatham; Peter Winch; Mark Galantowicz; Ralf Holzer
Journal:  Congenit Heart Dis       Date:  2011-12-16       Impact factor: 2.007

7.  Independent factors associated with mortality, reintervention, and achievement of complete repair in children with pulmonary atresia with ventricular septal defect.

Authors:  Kerstin M Amark; Tara Karamlou; Aoife O'Carroll; Cathy MacDonald; Robert M Freedom; Shi-Joon Yoo; William G Williams; Glen S Van Arsdell; Christopher A Caldarone; Brian W McCrindle
Journal:  J Am Coll Cardiol       Date:  2006-03-20       Impact factor: 24.094

8.  Sildenafil therapy in complex pulmonary atresia with pulmonary arterial hypertension.

Authors:  Zek S Lim; Joseph J Vettukattill; Anthony P Salmon; Gruschen R Veldtman
Journal:  Int J Cardiol       Date:  2007-11-14       Impact factor: 4.164

9.  A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow.

Authors:  S Nakata; Y Imai; Y Takanashi; H Kurosawa; K Tezuka; M Nakazawa; M Ando; A Takao
Journal:  J Thorac Cardiovasc Surg       Date:  1984-10       Impact factor: 5.209

10.  Pulmonary atresia, VSD and Mapcas: repair without unifocalization.

Authors:  Christian P Brizard; Matthew Liava'a; Yves d'Udekem
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2009
View more
  1 in total

1.  Current era outcomes of pulmonary atresia with ventricular septal defect: A single center cohort in Thailand.

Authors:  Kanthalas Lertsakulpiriya; Chodchanok Vijarnsorn; Prakul Chanthong; Paweena Chungsomprasong; Supaluck Kanjanauthai; Kritvikrom Durongpisitkul; Jarupim Soongswang; Thaworn Subtaweesin; Somchai Sriyoschati
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.